CapsoVision Schedule 13G/A: Holders Report ≤5% Ownership
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CapsoVision, Inc. received an Amendment No. 1 filing on Schedule 13G/A reporting that the named reporting persons (CID Greater China Venture Capital Fund III, L.P.; CID Venture Capital General Partner III, Limited; Altenza International Limited; Ching Yi Chang; and Chih Cheng Chang) each hold 5 percent or less of the company's common stock as reflected on the cover responses. The filing lists organizational details, business addresses, citizenship, and voting/dispositive power entries showing 0 sole and shared voting and dispositive power in the visible rows. The filing is signed by Ching Yi Chang and Chih Cheng Chang with signature dates of 04/07/2026; the cover page date shown is 03/31/2026.
Key Figures
Key Terms
Schedule 13G/A regulatory
Beneficially owned financial
Sole Voting Power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the CapsoVision (CV) Schedule 13G/A amendment state about ownership?
Who filed the Schedule 13G/A amendment for CapsoVision (CV)?
When were the signatures and cover date on the CapsoVision (CV) amendment filed?
Does the Schedule 13G/A list any sole voting or dispositive power for the reporting persons?
AI-generated analysis. How Rhea-AI works. Not financial advice.